Euro-Med Laboratories Philippines (PHS:EURO) Total Stockholders Equity: ₱6,271 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PHS:EURO Euro-Med Laboratories Philippines Inc PHS:EURO
80 GF Score
Price ₱1.13
GF Value ₱1.06
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Euro-Med Laboratories Philippines Total Stockholders Equity?

Euro-Med Laboratories Philippines PHS:EURO -0.88% 80 Total Stockholders Equity is ₱6,271 Mil as of Jun. 2026. GuruFocus rates PHS:EURO with a GF Score™ of 80/100 and a GF Value™ of ₱1.06 (Fairly Valued). The stock has 5 warning signs investors should review.

Euro-Med Laboratories Philippines's Total Stockholders Equity for the quarter that ended in Jun. 2026 was ₱6,271 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Euro-Med Laboratories Philippines's Book Value per Share for the quarter that ended in Jun. 2026 was ₱1.52. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Euro-Med Laboratories Philippines's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.64.

Euro-Med Laboratories Philippines  (PHS:EURO) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Euro-Med Laboratories Philippines's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(6270.549-0)/4112.141
=1.52

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Euro-Med Laboratories Philippines's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(3080.574 + 937.926) / 6270.549
=0.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Euro-Med Laboratories Philippines Total Stockholders Equity Related Terms

Euro-Med Laboratories Philippines Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Euro-Med Laboratories Philippines's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Euro-Med Laboratories Philippines Total Stockholders Equity Chart

Euro-Med Laboratories Philippines Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,640.68 5,708.92 5,845.19 5,882.90 6,068.16

Euro-Med Laboratories Philippines Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,042.49 6,172.59 6,068.16 6,153.25 6,270.55
PHS:EURO
80GF Score
Euro-Med Laboratories Philippines Inc PHS:EURO
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of ₱6,271 Mil mean?
Euro-Med Laboratories Philippines (PHS:EURO) has a Total Stockholders Equity of ₱6,271 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Euro-Med Laboratories Philippines and its competitors.
Is Euro-Med Laboratories Philippines' Total Stockholders Equity too high?
Euro-Med Laboratories Philippines' current Total Stockholders Equity is ₱6,271 Mil. Overall, Euro-Med Laboratories Philippines has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Euro-Med Laboratories Philippines' Total Stockholders Equity compare to ZTS and UTHR?
Euro-Med Laboratories Philippines' Total Stockholders Equity of ₱6,271 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Drug Manufacturers company?
A good Total Stockholders Equity depends on the Drug Manufacturers industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Euro-Med Laboratories Philippines and its competitors. Euro-Med Laboratories Philippines's current Total Stockholders Equity is ₱6,271 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euro-Med Laboratories Philippines stock overvalued right now?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines (PHS:EURO) is currently considered Fairly Valued. The stock's GF Value™ is ₱1.06, compared to a current price of ₱1.13 — trading 6.6% above its estimated fair value. The current Total Stockholders Equity is ₱6,271 Mil. Euro-Med Laboratories Philippines' overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Euro-Med Laboratories Philippines (PHS:EURO), the current Total Stockholders Equity is ₱6,271 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Euro-Med Laboratories Philippines (PHS:EURO) Overvalued in 2026?

Based on GuruFocus' analysis, Euro-Med Laboratories Philippines stock appears to be overvalued. The current stock price of ₱1.13 is trading 6.6% above its estimated GF Value™ of ₱1.06. GuruFocus considers Euro-Med Laboratories Philippines to be Fairly Valued.

Key valuation signals for PHS:EURO:

  • Total Stockholders Equity: ₱6,271 Mil
  • GF Value™: ₱1.06 vs. price of ₱1.13 (6.6% above fair value)
  • GF Score™: 80/100 with 5 warning signs

No single metric tells the full story. See the PHS:EURO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Euro-Med Laboratories Philippines Business Description

Address San Marcelino Street, United Nations Avenue corner, PPL Building, 2nd floor, Manila, PHL, 1000
Euro-Med Laboratories Philippines Inc is a pharmaceutical-based company that engages in the manufacture of pharmaceutical products such as large and small-volume parenterals and other solutions. The company also manufactures sterile water for injection, and other solutions such as ophthalmic, inhalation, irrigation, and dialysis. The Company also manufactures intravenous fluids in glass bottles, hemodialysis concentrates, ophthalmic products and disinfectants.
80GF Score

Get the complete analysis for PHS:EURO

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₱1.13
Price
₱1.06
GF Value